Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02420002Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by CHU Nîmes. Primary endpoints: Failure of pain control at Day 0 and Face Legs Activity Cry Consolability Observational Tool. Started Oct 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02420002.